课题基金 / 基金详情

FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY

FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
用于血管手术的融合矩阵与对照局部止血剂
批准号：
6263757
负责人：
FRED A WEAVER
金额：
$3.56万
依托单位：
UNIVERSITY OF SOUTHERN CALIFORNIA
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6263757
关键词：
biomaterial development /preparation cardiovascular surgery clinical research hemostatics human subject surgery material /equipment

项目摘要

项目成果

FRED A WEAVER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The study will determine the safety & effectiveness of fusion matrix. Each patient undergoing vascular surgery may present with multiple-bleeding sites during surgery. All bleeding sites in a given patient will be treated with either fusion matrix or the control topical hemostatic agent (gelfoam + thrombin). Analysis will be performed for the total number of bleeding episodes encountered where treatment is attempted.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
FUSION MATRIX VS CONTROL TOPICAL HEMOSTAT FOR VASCULAR SURGERY
IV LIPO PGE THERAPY IN PATIENTS WITH ISCHEMIC ULCERS
ORAL ILOPROST ADMINISTERED FOR SEVERE PERIPHERAL ARTERIAL OCCLUSION
海外基金